January 8, 2018 — Corindus Vascular Robotics Inc. announced that it is working with Mayo Clinic in a preclinical study about use of telestenting. Telestenting, a remote robotic treatment for percutaneous coronary intervention (PCI), may enable physicians to conduct procedures from virtually any location, opening opportunities for more patients globally to receive the benefits of this lifesaving procedure. The global shortage of PCI-capable operators is significant and continues to be a growing problem.
Mackram F. Eleid, M.D., interventional cardiologist, Mayo Clinic Department of Cardiovascular Medicine, associate professor of medicine, Mayo Clinic College of Medicine, will serve as the primary investigator for the multi-phase study.
Mayo Clinic received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the first step of a multi-phase, multi-year development program. Mayo Clinic is working with Corindus to explore telestenting as a solution to the geographic and workforce barriers that exist to provide needed PCI therapy to rural and underserved populations across the globe. Studies will help determine if robotic-assisted PCI can be performed safely and effectively using an off-site remote-controlled system. The CorPath GRX System is currently cleared for robotic-assisted PCI in the cardiac cath lab.
For more information: www.corindus.com
March 18, 2024 
